Amyvid

Active Ingredient(s): Florbetapir F 18
FDA Approved: * April 6, 2012
Pharm Company: * AVID RADIOPHARMACEUTICALS
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Amyvid Overview

Positron-emission tomography (PET)[1] is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body as an aid to the diagnosis of disease. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide, most commonly fluorine-18. which is introduced into the body on a biologically active molecule called a radioactive tracer. Three-dimensional images of tracer concentration within the body are then con...

Read more Amyvid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Positron_emission_tomography

Recent Amyvid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Florbetapir F 18
  • Injection: 370mbq
  • Solution: 10-30ml (13.5-51mci/ml), 10-50ml (13.5-51cmi/ml), 10-50ml (13.5-51mci/ml), 10ml (13.5-51mci/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Amyvid: (1 result)

Sorted by National Drug Code
  • 0002-1200 Amyvid 51 mci/Ml Intravenous Injection, Solution by Eli Lilly and Company

Other drugs which contain Florbetapir F 18 or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA